Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?
Sofia España FernandezChen SunCarme Solé-BlanchAram BoadaAnna Martínez-CardúsJosé Luis ManzanoPublished in: Pharmaceutics (2023)
It is possible to resume or rechallenge, but each patient should be evaluated by a multidisciplinary team for close monitoring and assessment of the risk/benefit ratio before initiating treatment.